EVIO

EVIO Operating Cash Flow

The Operating Cash Flow of EVIO (EVIO) as of Nov 3, 2026 is -652,000.00 USD. In the previous year, Operating Cash Flow was 129,000.00 USD — a change of -605.43% (lower).

Operating Cash Flow

-652,000.00USD

YoY

-605.43%

Last updated:

Operating Cash Flow of EVIO is 2022 -652,000.00 USD. Operating Cash Flow of EVIO was 2021 129,000.00 USD. It decreases by -605.43% lower compared to the previous year.

The EVIO Operating Cash Flow history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Operating Cash Flow
Date
Operating Cash Flow
Jan 1, 2015
-194,734.00 USD
Jan 1, 2016
-276,951.00 USD
Jan 1, 2017
-587,665.00 USD
Jan 1, 2018
-4.38 M USD
Jan 1, 2019
-4.38 M USD
Jan 1, 2020
-1.98 M USD
Jan 1, 2021
129,000.00 USD
Jan 1, 2022
-652,000.00 USD
The EVIO Operating Cash Flow history
YEAROperating Cash FlowYoY
-652,000.00USD-605.43%
129,000.00USD-106.51%
-1.98 MUSD-54.72%
-4.38 MUSD0.00%
-4.38 MUSD+644.92%
-587,665.00USD+112.19%
-276,951.00USD+42.22%
-194,734.00USD+56.04%
-124,800.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

EVIO Stock analysis

What does EVIO do? EVIO, Inc. generates revenue through analytical testing services for cannabis and hemp products, targeting agricultural and pharmaceutical industries. The company operates subsidiaries including Smith Scientific Industries, LLC, Greenhaus Analytical Labs, LLC, and Viridis Analytics, LLC, which provide testing to verify regulatory compliance for product sales. Residential and commercial construction services form another revenue stream, while research and development and consulting services cater to cannabis and hemp industry participants. Subsidiaries such as EVIO Labs OR, Inc., C3 Labs, LLC, and EVIO Labs Humboldt, LLC further support the company's service offerings. The primary customers for EVIO's testing services are businesses within the cannabis and hemp sectors requiring regulatory verification. Construction services are sold to residential and commercial clients, while R&D and consulting services target industry participants seeking expertise. Subsidiaries like Keystone Labs, Inc. contribute to the analytical testing segment, ensuring compliance with market requirements. EVIO's revenue model relies on multiple service lines across different industry segments without relying on external partnerships or third-party platforms. EVIO's service portfolio includes analytical testing, construction, and consulting, with all operations managed through its subsidiaries. The company's focus on regulatory compliance for cannabis and hemp products drives demand for its testing services. Construction services provide additional revenue, while R&D and consulting support industry growth. Subsidiaries such as Smith Scientific Industries, LLC and Greenhaus Analytical Labs, LLC operate under the EVIO brand to deliver specialized services to clients in the agricultural and pharmaceutical sectors. EVIO is one of the most popular companies on Eulerpool.

Frequently Asked Questions about EVIO stock

Operating Cash Flow of EVIO is -652,000.00 USD in 2022.

Operating Cash Flow of EVIO changed from 129,000.00 USD to -652,000.00 USD, representing a -605.43% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Operating Cash Flow EVIO since 2006 – with annual values, charts, and detailed analysis.

Operating cash flow measures the cash generated from core business operations. It is a pure measure of a company's ability to generate cash.

Operating Cash Flow's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Operating Cash Flow's EVIO historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — EVIO

All Key Metrics — EVIO